GANX: Gain Therapeutics, Inc. Stock

by  •  • Comments Off on GANX: Gain Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 57.82
Enterprise Value ($M) 46.27
Book Value ($M) 8.91
Book Value / Share 0.34
Price / Book 6.49
NCAV ($M) 8.29
NCAV / Share 0.31
Price / NCAV 6.98

Profitability (mra)
Return on Invested Capital (ROIC) -2.21
Return on Assets (ROA) -1.15
Return on Equity (ROE) -1.70

Liquidity (mrq)
Quick Ratio 2.99
Current Ratio 2.99

Balance Sheet (mrq) ($M)
Current Assets 13.74
Assets 14.37
Liabilities 5.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-22 33,638 117,523 28.62
2025-01-21 31,526 133,269 23.66
2025-01-17 108,903 268,821 40.51

(click for more detail)

Similar Companies
FHTX – Foghorn Therapeutics Inc. FOLD – Amicus Therapeutics, Inc.
FULC – Fulcrum Therapeutics, Inc. GHRS – GH Research PLC
HCWB – HCW Biologics Inc.


Financial data and stock pages provided by
Fintel.io